EGFR | Afatinib, Erlotinib, Dacomitinib, Gefitinib, Osimertinib, Racucirumab, Amivantamab-vmjw |
EGFR wildtype | Atezolizumab, Ipilimumab, Nivolumab, Pembrolizumab |
ALK | Alectinib, Brigatinib, Ceritinib, Crizotinib, Lorlatinib |
ALK wildtype | Atezolizumab, Ipilimumab, Nivolumab, Pembrolizumab |
ROS1 | Crizotinib, Entrectinib |
BRAF | Dabrafenib, Trametinib |
MET | Capmatinib, Tepotinib |
RET | Pralsetinib, Selpercatinib |
KRAS | Sotorasib |
NTRK1/2/3 fusions | Larotrectinib, Entrectinib |
MSI | Pembrolizumab |